API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.clinicaltrialsarena.com/news/innate-pharma-mycosis-fungoides-trial/
https://www.globenewswire.com/news-release/2021/09/15/2297150/0/en/Innate-Pharma-reports-first-half-2021-financial-results-and-business-update.html
https://www.globenewswire.com/news-release/2021/06/22/2250847/0/en/Innate-Pharma-presents-preliminary-data-from-TELLOMAK-trial-showing-clinical-response-for-lacutamab-in-mycosis-fungoides.html
https://www.globenewswire.com/news-release/2021/06/09/2244176/0/en/New-Lacutamab-Data-From-Tellomak-Trial-to-be-Showcased-in-Oral-Presentation-at-Upcoming-16th-International-Conference-on-Malignant-Lymphoma.html
https://www.innate-pharma.com/en/news-events/press-releases/innate-pharma-receives-prime-designation-european-medicines-agency-lacutamab-sezary-syndrome